Exchange: NASDAQ·Updated 09:33 AM EDT

ANEB Anebulo Pharmaceuticals Inc

$0.315
$0.015
(4.54%)
Today
Reported EarningsFeb 12
Mkt Cap$12.85M
Vol100.00

About ANEB

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
46

Neutral Sentiment

How do you feel about ANEB?

Advertisement|Remove ads.